Recent research carried out by a team of researchers in Japan has investigated the use of bone marrow transplants (BMTs) to treat hypophosphatasia (HPP). In this study, the researchers carried out BMT for two infants with HPP in combination with allogenic (other-donated) mesenchymal stem cell transplants (MSCTs). The allogenic MSC donors were a parent of the infant.
from The Medical News http://ift.tt/1FtiUmt
from The Medical News http://ift.tt/1FtiUmt
No comments:
Post a Comment